Fishman M - Search Results

1

The histogenic origin of melanoma arising in respiratory epithelium of a teratomatous germ cell tumor of the mediastinum: an enigma unraveled from an unlikely source.

McNab P, Quigley B, Mendoza T, Hakam A, Khalil F, Fishman M, Altiok S. McNab P, et al. Among authors: fishman m. Int J Clin Exp Pathol. 2012;5(9):982-90. Epub 2012 Oct 20. Int J Clin Exp Pathol. 2012. PMID: 23119117 Free PMC article.

2

Regression of metastatic clear cell kidney cancer with interleukin-2 treatment following nivolumab (anti-PD-1) treatment.

Brayer J, Fishman M. Brayer J, et al. Among authors: fishman m. J Immunother. 2014 Apr;37(3):187-91. doi: 10.1097/CJI.0000000000000024. J Immunother. 2014. PMID: 24598453

3

Changes in dendritic cell phenotype after a new high-dose weekly schedule of interleukin-2 therapy for kidney cancer and melanoma.

Finkelstein SE, Carey T, Fricke I, Yu D, Goetz D, Gratz M, Dunn M, Urbas P, Daud A, DeConti R, Antonia S, Gabrilovich D, Fishman M. Finkelstein SE, et al. Among authors: fishman m. J Immunother. 2010 Oct;33(8):817-27. doi: 10.1097/CJI.0b013e3181ecccad. J Immunother. 2010. PMID: 20842055 Clinical Trial.

4

Survival Outcomes Associated With Female Primary Urethral Carcinoma: Review of a Single Institutional Experience.

Peyton CC, Azizi M, Chipollini J, Ercole C, Fishman M, Gilbert SM, Juwono T, Lockhart J, Poch M, Pow-Sang JM, Spiess PE, Wiegand L, Sexton WJ. Peyton CC, et al. Among authors: fishman m. Clin Genitourin Cancer. 2018 Oct;16(5):e1003-e1013. doi: 10.1016/j.clgc.2018.05.012. Epub 2018 May 18. Clin Genitourin Cancer. 2018. PMID: 29859736

5

Cytoreductive nephrectomy vs medical therapy as initial treatment: a rational approach to the sequence question in metastatic renal cell carcinoma.

Spiess PE, Fishman MN. Spiess PE, et al. Cancer Control. 2010 Oct;17(4):269-78. doi: 10.1177/107327481001700407. Cancer Control. 2010. PMID: 20861814 Free article. Review.

6

Management of metastatic renal cancer.

Thompson P, Fishman M. Thompson P, et al. Among authors: fishman m. J Natl Compr Canc Netw. 2005 Jan;3(1):105-13. doi: 10.6004/jnccn.2005.0006. J Natl Compr Canc Netw. 2005. PMID: 19813327 Review.

7

Phase I study of the taxane BMS-188797 in combination with carboplatin administered every 3 weeks in patients with solid malignancies.

Fishman MN, Garrett CR, Simon GR, Chiappori AA, Lush RM, Dinwoodie WR, Mahany JJ, Dellaportas AM, Cantor A, Gollerki A, Cohen MB, Sullivan DM. Fishman MN, et al. Clin Cancer Res. 2006 Jan 15;12(2):523-8. doi: 10.1158/1078-0432.CCR-05-0928. Clin Cancer Res. 2006. PMID: 16428495 Clinical Trial.

8

Sequential oral 9-nitrocamptothecin and etoposide: a pharmacodynamic- and pharmacokinetic-based phase I trial.

Simon GR, Lush RM, Gump J, Tetteh L, Williams C, Cantor A, Antonia S, Garrett C, Rocha-Lima C, Fishman M, Sullivan DM, Munster PN. Simon GR, et al. Among authors: fishman m. Mol Cancer Ther. 2006 Aug;5(8):2130-7. doi: 10.1158/1535-7163.MCT-06-0034. Mol Cancer Ther. 2006. PMID: 16928835 Clinical Trial.

9

Review: therapy for kidney cancer with a sarcomatoid component.

Fishman M. Fishman M. Clin Adv Hematol Oncol. 2011 Jan;9(1):67-9. Clin Adv Hematol Oncol. 2011. PMID: 21326150 Review. No abstract available.

10

Growing opportunities for adjuvant therapy of renal cell carcinoma: targeted drugs and vaccines.

Rodriguez AR, Fishman MN. Rodriguez AR, et al. Expert Opin Pharmacother. 2007 Dec;8(17):2979-90. doi: 10.1517/14656566.8.17.2979. Expert Opin Pharmacother. 2007. PMID: 18001257 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

924 results

Search Page

Filters